RPRX · CUSIP G7709Q104
ROYALTY PHARMA PLC
Reported by 3 of 79 curated managers in Q2 2026, in the holdings snapshot last exported 2026-08-24.
- Managers holding
- 3
- Average portfolio weight
- 6.7%
- Combined reported value
- $373.3M
- Research group
- 79
3 of the 79 superinvestors Shameless Cloning tracks reported ROYALTY PHARMA PLC (RPRX) in their Q2 2026 13F filings, worth $373.3M combined, at an average 6.7% of their portfolios. The largest positions by portfolio weight belong to Pat Dorsey (8.8%), Samantha McLemore (6.7%), Torray Funds (4.6%).
Reporting managers
This is a historical 13F snapshot, not a live shareholder register. The count covers all matched managers; dashboard rankings use only those with at least 95% coverage. Reported value is measured at filing quarter-end, not at today's price.
| Manager / SEC filer | % of portfolio | Reported value |
|---|---|---|
| Pat DorseyDorsey Asset Management, LLC | 8.8% | $137.7M |
| Samantha McLemorePatient Capital Management, LLC | 6.7% | $201.8M |
| Torray FundsTorray Investment Partners LLC | 4.6% | $33.8M |